Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of Xian Yimucao Capsule in postpartum breastfeeding women
ChiCTR2600131586Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine Dongzhimen Hospital Luoyang Branch
- Start
- Feb 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xian Yimucao Capsule (2 arms), sponsored by Beijing University of Chinese Medicine Dongzhimen Hospital Luoyang Branch. Primary endpoints: Complete blood count, Routine urine test and 5 more. Started Feb 2026; status: recruiting.
02
Drugs
Xian Yimucao Capsule
Beyond the preview
Go deeper on ChiCTR2600131586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131586.